SAM SON1, AKSHAAR BRAHMBHATT1, KEN ZHAO1, BRETT MARINELLI1, JAMES HARDING2, WILLIAM JARNAGIN3, GHASSAN K. ABOU-ALFA2, HOOMAN YARMOHAMMADI1,*
Oncology Research, Vol.32, No.12, pp. 1831-1836, 2024, DOI:10.32604/or.2024.052985
- 13 November 2024
Abstract Background: This article aims to present the single-institution outcomes of patients with Fibrolamellar Carcinoma (FLC) treated with liver-directed therapies (LDT). Methods: In this single-center retrospective study, all patients diagnosed with FLC who underwent LDT were identified. Between July 2012 and July 2023, six patients were identified. One patient was excluded due to bleeding. Demographic and clinical parameters were recorded. Complications within 30 days of the LDT were evaluated. Radiological treatment responses at 1, 6, and 12 months were assessed per mRECIST. Results: A total of five patients, which included three females and two males, were reviewed.… More >
Login
Register
